Maria-Halima Laaberki

Maria-Halima Laaberki

Auto-generated profile, based on publicly available information

Maria-Halima Laaberki

CIRI, Center for Integrative Research in Infectious diseases and Immunology, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, Univ Lyon, 69007, Lyon, France

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Cell
Verified
Journal Article
Closed access
ISIshita M. Shah
Ishita M. Shah
MLMaria-Halima Laaberki
Maria-Halima Laaberki
DPDavid L. Popham
David L. Popham
JDJonathan Dworkin
Jonathan Dworkin

15 September 2008 in Journal of Bacteriology
Verified
Journal Article
Closed access
MLMaria-Halima Laaberki
Maria-Halima Laaberki
JDJonathan Dworkin
Jonathan Dworkin
Bacterial spores are resistant to a wide range of chemical and physical insults that are normally lethal for the vegetative form of the bacterium. While the integrity of the protein coat of the spore is crucial for spore survival in vitro, far less is known about how the coat provides protection in vivo against predation by ecologically relevant hosts. In particular, assays had characterized the in vitro resistance of spores to peptidoglycan-hydrolyzing enzymes like lysozyme that are also important effectors of innate immunity in a wide variety of hosts. Here, we use the bacteriovorous nematode Caenorhabditis elegans , a likely predator of Bacillus spores in the wild, to characterize the role of the spore coat in an ecologically relevant spore-host interaction. We found that ingested wild-type Bacillus subtilis spores were resistant to worm digestion, whereas vegetative forms of the bacterium were efficiently digested by the nematode. Using B. subtilis strains carrying mutations in spore coat genes, we observed a correlation between the degree of alteration of the spore coat assembly and the susceptibility to the worm degradation. Surprisingly, we found that the spores that were resistant to lysozyme in vitro can be sensitive to C. elegans digestion depending on the extent of the spore coat structure modifications.

1 February 2006 in Microbiology
Verified
Journal Article
Open access
PDF file
SGSébastien Guiral
Sébastien Guiral
VHVincent Hénard
Vincent Hénard
MLMaria-Halima Laaberki
Maria-Halima Laaberki
CGChantal Granadel
Chantal Granadel
MPMarc Prudhomme
Marc Prudhomme
JCJean-Pierre Claverys
Jean-Pierre Claverys
In this paper, the construction and evaluation of a chromosomal expression platform (CEP), which allows controlled gene expression following ectopic integration into the chromosome ofStreptococcus pneumoniae, is described. CEP is based on the well-studied maltosaccharide-inducible system. To facilitate integration at CEP, a plasmid, pCEP, capable of replication inEscherichia coli, but not inS. pneumoniae, was assembled. This plasmid contains an expression/selection cassette flanked on each side by more than 2 kb of pneumococcal DNA. The cassette comprises a maltose-inducible promoter, PM, separated from a kanamycin-resistance gene byNcoI andBamHI cloning sites. Clones harbouring the gene of interest integrated at CEP under the control of PMcan be obtained through direct transformation of anS. pneumoniaerecipient with ligation products between that gene andNcoI/BamHI-digested pCEP DNA, followed by selection for kanamycin-resistant transformants.

1 August 2006 in International Journal of Medical Microbiology
Verified
Journal Article
Closed access
MLMaria-Halima Laaberki
Maria-Halima Laaberki
NJNazila Janabi
Nazila Janabi
Eric OswaldEric Oswald
Eric Oswald
FRFrancis Repoila
Francis Repoila

22 February 2022 in mBio
Verified
Journal Article
Open access
AGAnne-Sophie Godeux
Anne-Sophie Godeux
ESElin Svedholm
Elin Svedholm
SBSamuel Barreto
Samuel Barreto
APAnais Potron
Anais Potron
SVSamuel Venner
Samuel Venner
MLMaria-Halima Laaberki
Maria-Halima Laaberki
Acinetobacter baumannii is a multidrug-resistant pathogen responsible for difficult-to-treat hospital-acquired infections. Understanding the mechanisms leading to the emergence of the multidrug resistance in this pathogen today is crucial.

1 February 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MLMaria-Halima Laaberki
Maria-Halima Laaberki
JPJohn Pfeffer
John Pfeffer
ACAnthony J. Clarke
Anthony J. Clarke
JDJonathan Dworkin
Jonathan Dworkin
O-Acetylation of the MurNAc moiety of peptidoglycan is typically associated with bacterial resistance to lysozyme, a muramidase that serves as a central component of innate immunity. Here, we report that the peptidoglycan of Bacillus anthracis, the etiological agent of anthrax, is O-acetylated and that, unusually, this modification is produced by two unrelated families of O-acetyltransferases. Also, in contrast to other bacteria, O-acetylation of B. anthracis peptidoglycan is combined with N-deacetylation to confer resistance of cells to lysozyme. Activity of the Pat O-acetyltransferases is required for the separation of the daughter cells following bacterial division and for anchoring of one of the major S-layer proteins. Our results indicate that peptidoglycan O-acetylation modulates endogenous muramidase activity affecting the cell-surface properties and morphology of this important pathogen.